论文信息 - The tyrosine-kinase inhibitor sunitinib targets vascular endothelial (VE)-cadherin: a marker of response to antitumoural treatment in metastatic renal cell carcinoma - 字舞流文

The tyrosine-kinase inhibitor sunitinib targets vascular endothelial (VE)-cadherin: a marker of response to antitumoural treatment in metastatic renal cell carcinoma

G. Pagès | J. Quesada | J. Ferrero | A. Sidibé | O. Filhol | C. Cochet | B. Escudier | M. Dufies | S. Négrier | Abir Khalil-Mgharbel | H. Polena | I. Vilgrain | C. Roelants | D. Borchiellini | A. Salomon | A. Deroux | E. Blanc | Julie Creuzet | Céline Ferlay-Segura